JOEL LEWIS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GALECTIN THERAPEUTICS INC

Filing Date Source Excerpt
2017-11-07 Joel Lewis. 47 Director n/a ... We expect each of the Series B Nominees to serve on one or more committees of the Board, which will be determined following the 2017 Annual Meeting.
2018-04-11 Joel Lewis (1) (2) ... Age 48 ... Position Director ... after which Dr. Gilbert S. Omenn (chair), Gilbert F. Amelio, Ph.D. and Joel Lewis were the Compensation Committee ... replaced by Joel Lewis and Stephen Shulman on the Audit Committee ... Total ($) 172,019.
2019-10-17 Joel Lewis (1) (2) ... Age 49 ... Member of audit committee ... Member of compensation committee ... Joel Lewis 55,000 ... Total 55,000
2020-10-19 Joel Lewis ... Age 50 ... Director since 2017 ... became our President and Chief Executive Officer on September 2, 2020 ... The Compensation Committee members were Dr. Gilbert S. Omenn (chair), Gilbert F. Amelio, Ph.D. and Joel Lewis. The Audit Committee members were Joel Lewis (chair), Kevin D. Freeman and Kary Eldred. ... Total ($) 189,098
2021-10-12 Joel Lewis, a director since 2017, became our President and Chief Executive Officer on September 2, 2020... Total ($) 146,497
2022-10-17 Joel Lewis, a director since 2017, became our President and Chief Executive Officer on September 2, 2020... The following table summarizes the compensation paid to our NEOs for the fiscal years ended December 31, 2021 and 2020... Joel Lewis, Chief Executive Officer & President... Total ($) 1,167,621.
2023-10-06 Joel Lewis ... Age 53 ... became our President and Chief Executive Officer on September 2, 2020. ... Joel Lewis, Chief Executive Officer & President ... Total ($) 974,181
2024-12-03 Joel Lewis, a director since 2017, became our President and Chief Executive Officer on September 2, 2020. ... Joel Lewis, Chief Executive Officer & President ... 2023 ... Total ... $963,647

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06